Please login to the form below

Not currently logged in
Email:
Password:

PwC

This page shows the latest PwC news and features for those working in and with pharma, biotech and healthcare.

Roche biggest pharma R&D spender in PwC survey

Roche biggest pharma R&D spender in PwC survey

Roche biggest pharma R&D spender in PwC survey. Pharma giant on track to spend 21.9% of its total revenue on research this year. ... PwC expects, such creating “robust, autonomous nodes”in these countries even if their main headquarters lies elsewhere

Latest news

  • Janssen’s quest to prevent diseases taking hold Janssen’s quest to prevent diseases taking hold

    As proof, van Hoof points to recent analysis from PwC’s Pharma 2020, The Vision, report which stated: ‘As the global population grows and ages, and demand for better healthcare management

  • La La Land? The myth of multichannel excellence La La Land? The myth of multichannel excellence

    58% of customers prefer to receive marketing promotions via email over social, print or text message (PwC).

  • Celebrating excellence Celebrating excellence

    This year entries were assessed by a panel of experienced, independent industry judges from the likes of EY, Quintiles, Engage, PA Consulting, Cello Health Consultancy and PwC, as well as patient

  • AbbVie takes Company of the Year at PMEA 2015 AbbVie takes Company of the Year at PMEA 2015

    This year entries were assessed by an experienced panel of experienced, independent industry judges from the likes of EY, Quintiles, Engage, PA Consulting, Cello Health Consultancy and PWC, as well as

  • PMEA 2015 now open for entry PMEA 2015 now open for entry

    Entries will be assessed by an experienced panel of experienced, independent industry judges from the likes of EY, Quintiles, Engage, PA Consulting, Cello Health Consultancy and PWC, as well as patient

More from news
Approximately 0 fully matching, plus 43 partially matching documents found.

Latest Intelligence

  • Pushing the accelerator Pushing the accelerator

    Take the case of a pharmaceutical company that worked with PwC to find out why a promising cancer drug kept failing in some phase III trials and to pinpoint suitable patient

  • Deal Watch December 2015 Deal Watch December 2015

    December saw the release of reports by two of the top accountancy and consulting groups, PWC and Deloitte. ... PWC's report Top Health Industry Issues of 2016 - Thriving in the New Health Economy describes, among many other interesting points, that 2016

  • Delivering accessible healthcare Delivering accessible healthcare

    Partner, Pharmaceuticals &Lifesciences Practice, PwC. 19th May 2015.

  • Sales reps in the digital age Sales reps in the digital age

    Chris has deep experience of CRM, Business Intelligence, and Business Consulting through formative years at organisations such as Dendrite, IMS Health, and PWC Consulting.

  • Evolution or revolution? Evolution or revolution?

    As explained by Jo Pisani, a Partner with PwC’ s European Pharmaceuticals &Lifesciences practice, if patients can be encouraged to self-diagnose, self-treat and self-pay, it can lead to

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Genoscience Pharma expands board of directors Genoscience Pharma expands board of directors

    He most recently served as Pharmcyclics' chief financial officer and treasurer and has also held management positions at ZELTIQ Aesthetics and PriceWaterhouseCoopers, where he worked in PwC's San Jose office

  • PwC appoints Issy Corbett as healthcare M&A partner PwC appoints Issy Corbett as healthcare M&A partner

    PwC appoints Issy Corbett as healthcare M&A partner. He brings experience from the Rothschild Group. ... Andrew McKechnie, partner and head of healthcare deals at PwC, said: “ Issy's experience and reputation in healthcare M&A is market-leading. “

  • Steve Arlington joins Pistoia Alliance Steve Arlington joins Pistoia Alliance

    Steve Arlington joins Pistoia Alliance. Former PwC partner takes up role as the innovationnon-profit's president. ... The Pistoia Alliance has appointed former PwC partner Steve Arlington as its new president.

  • Adaptimmune appoints Lawrence Alleva to its board Adaptimmune appoints Lawrence Alleva to its board

    Adaptimmune appoints Lawrence Alleva to its board. The former PwC partner will also chair its boardaudit committee. ... Adaptimmune has appointed former PwC partner Lawrence (Larry) Alleva to its board of directors as an independent, non-executive

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics